WALTHAM, Mass., May 7 /PRNewswire-FirstCall/ -- Interleukin Genetics, Inc. (AMEX: ILI), announced today that it will host a conference call and webcast on Wednesday, May 14, 2008 at 4:30 p.m. ET to review the Company's first quarter 2008 financial results and provide an update on recent corporate developments.
To access the live call, dial 877-627-6555 (domestic) or 719-325-4869 (international). The live webcast will be available on the Investors section of the Company's website, http://www.ilgenetics.com.
Replay access of the teleconference will be available for one week following the call by dialing 888-203-1112 (domestic) or 719-457-0820 (international). The passcode for the replay is 4243283. The webcast will be archived following the call at http://www.ilgenetics.com.
About Interleukin Genetics
Interleukin Genetics, Inc. (AMEX: ILI) is a genetics-focused
personalized health company that develops preventive consumer products and
genetic tests for sale to the emerging personalized health market. Focused
on the future of health and medicine, Interleukin uses its leading genetics
research and scientific capabilities to develop and test innovative
preventive and therapeutic products. Interleukin currently offers an array
of Nutraceuticals and OTCeuticals(R), including Ginkoba(R), Ginsana(R) and
Venastat(R) which are sold at the nation's largest food, drug and mass
retailers, and has com
|SOURCE Interleukin Genetics, Inc.|
Copyright©2008 PR Newswire.
All rights reserved